Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Jazz Pharmaceuticals News

    102,50 € 0,00% +0,00 €
    11:13:12 Uhr Gettex aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1JS1K
    ISIN: IE00B4Q5ZN47
    US-Symbol: JAZZ
    Typ: Aktie

    Jazz Pharmaceuticals News

    17.04.24 - PR Newswire
    Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
    Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024 PR Newswire
    17.04.24 - PR Newswire
    Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
    Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024 PR Newswire
    10.04.24 - PR Newswire
    Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
    Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting PR Newswire
    02.04.24 - PR Newswire
    Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
    Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer PR Newswire
    30.03.24 - Small- & Micro Cap Investment
    Teillegalisierung ist gute Nachricht für Cannabis-Aktien – SynBiotic, TerrAscend und Jazz Pharmaceuticals
    Am 23. Februar 2024 gab der Bundestag grünes Licht: die Cannabis-​Legalisierung kann kommen. Zumindest zum Teil. Ab 1. April 2024 dürfen Volljährige in Deutschland unter ...
    29.03.24 - wallstreet:online Zentralredaktion
    High Performance: Bietet der Cannabis-Sektor jetzt eine Tenbagger-Chance?
    Der Cannabis-​Markt wurde in den vergangenen Jahren stark abgestraft, besitzt aber weiterhin Wachstumspotenzial. Wichtig ist jedoch eine genaue Differenzierung zwischen den ...
    23.03.24 - Small- & Micro Cap Investment
    Cannabismarkt emanzipiert sich – TerrAscend, Aurora Cannabis und AbbVie
    „Marihuana ist die Heilung einer Nation, Alkohol die Zerstörung“, sagte die Reggae-​Legende Bob Marley einmal. Die Regierungsverantwortlichen fast aller Nationen sahen das zu ...
    17.03.24 - Small- & Micro Cap Investment
    Teillegalisierung: Zeit für Cannabis-Aktien? SynBiotic, TerrAscend und Jazz Pharmaceuticals
    Am 23. Februar 2024 gab der Bundestag grünes Licht: die Cannabis-​Legalisierung kann kommen. Zumindest zum Teil. Ab 1. April 2024 dürfen Volljährige in Deutschland unter ...
    12.03.24 - PR Newswire
    Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
    Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024 PR Newswire
    12.03.24 - PR Newswire
    Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
    Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024 PR Newswire
    10.03.24 - Small- & Micro Cap Investment
    Cannabismarkt weltweit im Wandel – TerrAscend, Aurora Cannabis und AbbVie
    „Marihuana ist die Heilung einer Nation, Alkohol die Zerstörung“, sagte die Reggae-​Legende Bob Marley einmal. Die Regierungsverantwortlichen fast aller Nationen sahen das zu ...
    05.03.24 - dpa-AFX
    UN-Drogenkontrollrat: Cannabis-Freigabe widerspricht UN-Übereinkommen
    Der UN-​Drogenkontrollrat (INCB) hat die deutsche Regierung auf die Unvereinbarkeit zwischen der geplanten Legalisierung von Cannabis und den bestehenden internationalen ...
    28.02.24 - PR Newswire
    Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
    Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance PR Newswire
    28.02.24 - PR Newswire
    Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
    Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance PR Newswire
    27.02.24 - PR Newswire
    Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors
    Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors PR Newswire
    27.02.24 - PR Newswire
    Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors
    Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors PR Newswire
    21.02.24 - PR Newswire
    Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
    Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer PR Newswire
    21.02.24 - PR Newswire
    Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
    Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer PR Newswire
    20.02.24 - PR Newswire
    Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences
    Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences PR Newswire
    20.02.24 - PR Newswire
    Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences
    Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences PR Newswire

    Newssuche

    Videos

    newspaper
    09:10 Uhr
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »